Purinergic signaling, DAMPs, and inflammation.


Journal

American journal of physiology. Cell physiology
ISSN: 1522-1563
Titre abrégé: Am J Physiol Cell Physiol
Pays: United States
ID NLM: 100901225

Informations de publication

Date de publication:
01 05 2020
Historique:
pubmed: 12 3 2020
medline: 4 8 2020
entrez: 12 3 2020
Statut: ppublish

Résumé

Danger sensing is one of the most fundamental evolutionary features enabling multicellular organisms to perceive potential threats, escape from risky situations, fight actual intruders, and repair damage. Several endogenous molecules are used to "signal damage," currently referred to as "alarmins" or "damage-associated molecular patterns" (DAMPs), most being already present within all cells (preformed DAMPs), and thus ready to be released, and others neosynthesized following injury. Over recent years it has become overwhelmingly clear that adenosine 5'-triphosphate (ATP) is a ubiquitous and extremely efficient DAMP (thus promoting inflammation), and its main metabolite, adenosine, is a strong immunosuppressant (thus dampening inflammation). Extracellular ATP ligates and activates the P2 purinergic receptors (P2Rs) and is then degraded by soluble and plasma membrane ecto-nucleotidases to generate adenosine acting at P1 purinergic receptors (P1Rs). Extracellular ATP, P2Rs, ecto-nucleotidases, adenosine, and P1Rs are basic elements of the purinergic signaling network and fundamental pillars of inflammation.

Identifiants

pubmed: 32159362
doi: 10.1152/ajpcell.00053.2020
doi:

Substances chimiques

Alarmins 0
Immunosuppressive Agents 0
Receptors, Purinergic P1 0
Receptors, Purinergic P2 0
Adenosine Triphosphate 8L70Q75FXE
Adenosine Triphosphatases EC 3.6.1.-
ectoATPase EC 3.6.1.-
Adenosine K72T3FS567

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

C832-C835

Commentaires et corrections

Type : CommentIn

Auteurs

Francesco Di Virgilio (F)

Department of Morphology, Surgery, and Experimental Medicine, University of Ferrara, Ferrara Italy.

Alba Clara Sarti (AC)

Department of Morphology, Surgery, and Experimental Medicine, University of Ferrara, Ferrara Italy.

Robson Coutinho-Silva (R)

Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH